AACR Virtual Annual Meeting II: Understanding Racial Disparities in Cancer
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
It is estimated that almost 40 percent of people in the United States will be diagnosed with cancer during their lifetimes and...
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...